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ABSTRACT 
In this thesis, we aimed to determine whether persons with cognitive impairment 
no dementia (CIND) were at higher risk for negative health outcomes, and if so, to 
stratify persons with CIND into high and low risk groups. We also aimed to 
determine the whether persons with CIND had a higher risk of negative health 
outcomes based on their underlying familial risk, or whether difficulties with 
medication played a part in the development of negative health outcomes. Lastly, 
we aimed to determine whether cardiovascular and antidepressant medication use 
modified the relationship between CIND and dementia.  
In Studies I and II, non-demented stroke patients who were recruited as part of the 
ESPRIT trial were followed up for up to five years.  In Study I, a novel method of 
stratifying CIND based on the severity of impairment, was compared to established 
MCI subtypes in the ability to predict dementia.  Having CIND-moderate increased 
the risk of dementia more than six times (HR 6.43, CI 1.30-31.7) while having 
multiple domain mild cognitive impairment with amnestic components increased 
the risk of dementia more than five times (HR 5.77, CI 1.19-28.0).   
In Study II, the effect of CIND and CIND severity on dependency, vascular events, 
and death were analyzed. Patients with CIND were three times more likely to 
become dependent (HR 3.77 CI 1.52 -9.37) and three times more prone to mortality 
(HR 3.27 CI 1.06-10.1). CIND severity was able to discriminate those at high risk of 
death, with patients with CIND-moderate (HR 3.81 CI 1.14-12.8) almost four times 
more likely to die as compared to non-cognitively impaired patients. 
In Studies III and IV, non-demented community dwelling twins who were assessed 
cognitively as part of a dementia study, HARMONY, were followed up negative 
outcomes with population-based registers. In Study III, we investigated the effect of 
CIND and Subjective Cognitive Impairment (SCI) on negative outcomes. CIND 
predicted hospitalization for dementia, death, and hospitalization in GEE analyses 
but not in within-pair analyses.  SCI predicted dementia in both GEE and with pair 
analyses but only predicted hospitalization in GEE analyses. These results 
suggested that the relationship between CIND and negative health outcomes is 
confounded by genetic and shared environmental influences while SCI is 
independently associated with negative health outcomes. Additionally, we found 
that difficulty with medication was an independent risk factor for both dementia 
and death.  
In Study IV, we aimed to determine whether medication use was associated with 
dementia, and whether individuals with CIND, SCI, or depression received more 
medication than their unimpaired counterparts. Antidepressant use, particularly 
the use of Selective Serotonin Reuptake Inhibitors (SSRIs) doubled the risk of 
dementia regardless of depression or cognitive status. Cardiovascular medications, 
particularly antihypertensive and lipid lowering agents halved the risk of dementia. 
In addition, we find that persons with CIND and SCI received less cardiovascular 
and more antidepressant medications than their non-impaired counterparts.  
Overall, this thesis shows that persons with CIND are at increased risk of negative 
health outcomes such as dementia, death, hospitalization, and disability.  CIND 
appears to be associated with negative health outcomes both due to difficulties with 
medication and due to the fact that CIND acts as a marker of underlying disease 
processes.  In addition, we find that persons with CIND get less cardiovascular 
medications and more antidepressant medications, both of which increase the risk 
of dementia. These findings suggest that persons with CIND are a high-risk group 
in which greater vigilance by health professionals may bring benefits. 
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